Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Attovia is spearheading the development of a diverse portfolio of biotherapeutics, primarily targeting immune-mediated diseases and oncology. Our approach centers around the utilization of ATTOBODY, an innovative biologics platform designed to produce small-format biparatopic binders, effectively tapping into the spatial dynamics of target engagement. The biparatopic binding mechanism exhibited by ATTOBODIES delivers exception...
Attovia is spearheading the development of a diverse portfolio of biotherapeutics, primarily targeting immune-mediated diseases and oncology. Our approach centers around the utilization of ATTOBODY, an innovative biologics platform designed to produce small-format biparatopic binders, effectively tapping into the spatial dynamics of target engagement. The biparatopic binding mechanism exhibited by ATTOBODIES delivers exceptional features such as picomolar affinity, adhesive-like off-rates, remarkable specificity, and enhanced target internalization.

List your booth number for exhibitions, ask us